Product Information
FT NICOTINE 4 MG LOZENGE is a generic product labeled by Strategic Sourcing Services LLC, priced at $0.3443 per EA under NDC 70677117501. Its NADAC has been published 126 times since May 8, 2024.
FDA first approved this application on Jul 10, 2009.
Strength
4 mg/1
Manufacturer
Strategic Sourcing Services LLCNDC
70677117501
Classification
Generic
Dosage Form
LOZENGE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
NICOTINEApproval Type
Generic (ANDA)
FDA Application
ANDA090821FDA Approved
7/10/2009
On Market Since
10/13/2023
Pharmacological Classes
Price Statistics
The NADAC for FT NICOTINE 4 MG LOZENGE has been published 126 times since May 8, 2024, and over the history we have for it it has risen 12.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3443 per EA |
|---|---|
| All-time high | $0.3567 (Sep 11, 2024) |
| All-time low | $0.3069 (May 8, 2024) |
| 52-week high | $0.3443 |
| 52-week low | $0.3269 |
| Median price | $0.3320 |
| Average price | $0.3310 |
| Largest weekly change | +14.9% (May 22, 2024) |
| Weeks tracked | 126 |
| Tracking since | May 8, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Strategic Sourcing Services LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Nicotine Polacrilex market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cholinergic Nicotinic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FT NICOTINE 4 MG LOZENGE?
The current National Average Drug Acquisition Cost (NADAC) for FT NICOTINE 4 MG LOZENGE, manufactured by Strategic Sourcing Services LLC, is $0.3443 per EA (NDC 70677117501), effective Sep 30, 2026.
How has the price of FT NICOTINE 4 MG LOZENGE changed over time?
Over the history we have for it, the NADAC for FT NICOTINE 4 MG LOZENGE has risen 12.2%. It has been tracked across 126 weekly CMS publications since May 8, 2024.
What are the highest and lowest recorded NADAC prices for FT NICOTINE 4 MG LOZENGE?
Since May 8, 2024, the NADAC for FT NICOTINE 4 MG LOZENGE has ranged from a low of $0.3069 (May 8, 2024) to a high of $0.3567 (Sep 11, 2024), with a median of $0.3320 per EA.
Are there cheaper alternatives to FT NICOTINE 4 MG LOZENGE?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FT NICOTINE 4 MG LOZENGE in a comparable dosage form, but none are currently priced below it.
Who manufactures FT NICOTINE 4 MG LOZENGE?
FT NICOTINE 4 MG LOZENGE (NDC 70677117501) is labeled by Strategic Sourcing Services LLC, and CMS classifies it as a generic product.